Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells

Cancer Science

Volumn 96, Issue 2, 2005, Pages 127-133

  Shi, Jun ^a   Ikeda, Kazuma ^b   Fujii, Nobuharu ^b   Kondo, Eisei ^b   Shinagawa, Katsuji ^b   Ishimaru, Fumihiko ^b   Kaneda, Kinuyo ^b   Tanimoto, Mitsune ^b   Li, Xiao ^a   Pu, Quan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD34 ANTIGEN; FAS LIGAND; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; APOPTOSIS REGULATORY PROTEIN; BACTERIAL POLYSACCHARIDE; CAPSULAR POLYSACCHARIDE 35A; MEMBRANE PROTEIN; TNFSF10 PROTEIN, HUMAN;

ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL ACTIVATION; CELL DAMAGE; CELL FUNCTION; CELL KILLING; CELL STIMULATION; CELL STRAIN HL 60; CELL SURFACE; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DAUDI CELL; DENDRITIC CELL; FLOW CYTOMETRY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; LEUKEMIA CELL LINE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD; APOPTOSIS; CELL CULTURE; CLONOGENIC ASSAY; FETUS BLOOD; IMMUNOLOGY; METABOLISM; NEOPLASM;

ANTIGENS, CD14; ANTIGENS, CD34; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; COLONY-FORMING UNITS ASSAY; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FETAL BLOOD; HL-60 CELLS; HUMANS; INTERFERON TYPE II; JURKAT CELLS; MEMBRANE GLYCOPROTEINS; NEOPLASMS; POLYSACCHARIDES, BACTERIAL; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 20144362968     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00017.x     Document Type: Article

References (29)

1. Steimman RM. The dendritic cells system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271-96.
2. Lu L, Qian S, Hershberger PA, Rudert WA, Lynch DH, Thomson AW. Fas-ligand (CD95) and B7 experssion on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol 1997; 158: 5676-84.
3. Trinite B, Voisine C., Yagita H, Josien R. A subset of cytolytic dendritic cell in rat. J Immunol 2000; 165: 4202-8.
4. Chapoval AI, Tanada K, Chen L. In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells. Blood 2000; 95: 2346-54.
5. Kato T, Yamane H, Nariuchi H. Differential effects of LPS and CD40 ligand stimulations on the induction of IL-12 production by dendritic cells and macrophages. Cell Immunol 1997; 181: 59-67.
6. Labeur MS, Roters B, Pers B, Mehling A, Luger TA, Schwarz T, Grabbe S. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol 1999; 162: 168-75.
7. Liu S, Yu Y, Zhang M, Wang W, Cao X. The involvement of TNF-α related apiptosis-inducing ligand in the enhanced cytotoxivity of IFN-β-stimulated human dendritic cells to tumor cells. J Immunol 2001; 166: 5407-15.
8. Fanger NA, Maliszewski CR, Schooley K, Griffith TS. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Exp Med 1999; 190: 1155-64.
9. Lu G, Janjic BM, Janjic J, Whiteside TL, Storkus WJ, Vujanovic NL. Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, Lymphotoxin-α1β2, Fas Ligand, and TNF-related apoptosis-inducing ligand. J Immunol 2002; 168: 1831-9.
10. Janjic BM, Lu G, Pimenov A, Whiteside TL, Storkus WJ, Vujanovic NL. Innate direct anticancer effect function of human immature dendritic cells. 1. Involvement of an apoptosis-inducing pathway. J Immunol 2002; 168: 1823-30.
11. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994; 180 83-93.
12. Cao X, Zhang W, He L, Xie Z, Ma S, Tao Q, Yu Y, Hamada H, Wang J. Lymphotactin gene-, modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity. J Immunol 1998; 161: 6238-44.
13. Karanikas V, Lodding J, Maino VC, McKenzie IF. Flow cytometric measurement of intracellular cytokines detects immune responses in MUC1 immunotherapy. Clin Cancer Res 2000; 6: 829-37.
14. Hanabuchi S, Koyanagi M, Kawasaki A, Shinohara N, Matsuzawa A, Nishimura Y, Kobayashi Y, Yagita SH, Okumura K. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci U S A 1994; 91: 4930-4.
15. Strunk D, Rappersberger K, Egger C, Strobl H, Kromer E, Elbe A, Maurer D, Stingl G. Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. Blood 1996; 87: 1292-302.
16. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC. Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 1997; 27: 431-41.
17. Crespo I, Paiva A, Couceiro A, Pimentel P, Orfao A, Regateiro F. Immunophenotypic and functional characterization of cord blood dendritic cells. Stem Cells Dev 2004; 13: 63-70.
18. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, Knop J, Enk AH. Pro-inflammatory cytokines and prostaglandins induce maturation of porent immunostimulatory dendritic cells under fetal calf-serum-free conditions. Eur J Immunol 1997; 27: 3135-42.
19. Vidalain PO, Azocar H, Yagita H, Rabourdin-Combe C, Sevet-Delprat C. Cytotoxic activity of human dendritic cells is differentially regulated by double-stranded RNA and CD40 ligand. J Immunol 2001; 167: 3765-72.
20. Vujanovic NL, Nagashima S, Herberman RB, Whiteside TL. Nonsecretory apoptotic killing by human NK cells. J Immunol 1996; 157: 1117-26.
21. Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR, Fanger NA. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine TRAIL. J Exp Med 1999; 189: 1343-54.
22. Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H. Expression and function of TNF-related apoptosis-inducing ligand on routine activated NK cells. J Immunol 1999; 163: 1909-13.
23. Vidalain PO, Azocar O, Lamouille B, Astier A, Rabourdin-Combe C, Servet-Delprat C. Measles virus induces functional TRAIL production by human dendritic cells. J Virol 2000; 74: 556-9.
24. Liu E, Tu W, Law HK, Lau YL. Decreased yield, phenotypic expression and function of immature monocyte-derived dendritic cells in cord blood. Br J Haematol 2001; 113: 240-6.
25. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271: 12687-90.
26. Nathalie V, Ezea A, Zoulikha A, Peter V, Micherl G, Fabienne W. Tummoricidal activity of monocyte-derived dendritic cells: evidence for a casoase-8-deoendent, Fas-associated death domain-independent mechanism. J Immunol 2001; 167: 3565-9.
27. Ayres FM, Narita M, Takahashi M, Yano T, Liu A, Toba K, Furukawa T, Aizawa Y. Human dendritic cells mediate anti-tumor activity against hematopoietic tumor cells without direct contact and Fas/FasL killing pathway. Oncol Rep 2004; 11: 1017-23.
28. Kashii Y, Giorda R, Herberman RB, Whiteside TL, Vujanovic NL. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J Immunol 1999; 163 5358-66.
29. Burdin N, Peronne C, Banchereau J, Rousset F. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J Exp Med 1993; 177: 295-304.